Disclosed herein are novel prostaglandin I.sub.2 (PGI.sub.2) derivatives exhibiting excellent in vivo duration and activities, said derivatives being represented by the general formula: ##STR1## wherein R.sub.1, X, R.sub.2 and R.sub.3 are as defined herein.
Ketoreductase (KRED)-catalyzed dynamic reductive kineticresolution (DYRKR) of α-substituted-β-keto arylphosphonates was developed as a generic and stereoselective approach to synthesize chiral α-substituted-β-hydroxy arylphosphonates, with moderate-to-excellent isolated yield (up to 96%), good-to-excellent diastereoselectivity (up to >99 : <1 dr), and excellent enantioselectivity (up to >99% ee) being
The highly chemo- and enantioselective hydrogenation of (E)-2-substituted-4-oxo-2-alkenoic acids was established for the first time using the Rh/JosiPhos complex, affording a series of chiral α-substituted-γ-keto acids with excellent results (up to 99% yield and >99% ee) and high efficiency (up to 3000 TON). In addition, the importance of this methodology was further demonstrated by a concise and gram-scale
Palladium‐Catalyzed Allylation of Vinylethylene Carbonates with
<i>β</i>
‐Ketophosphonates: Stereoselective Synthesis of (
<i>Z</i>
)‐Homoallylic Phosphonates
A first simple palladiumcatalyzedallylation of vinylethylene carbonates with β‐ketophosphonates has been developed. This method provides access to (Z)‐tri‐ and tetrasubstituted homoallylic phosphonates with exclusive regioselectivity, chemoselectivity and (Z)‐stereoselectivity. The reaction tolerates a wide substrate scope of vinylethylene carbonates and β‐ketophosphonates with electron‐donating
Disclosed herein are novel prostaglandin I2 (PGI2) derivatives exhibiting excellent in vivo duration and acitivities, said derivatives being represented by the general formula:
wherein R1, X, R2 and R3 are as defined herein.